The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index; 49 of the 56 sources its claims cite were checked for support.
cGAS–STING drives ageing-related inflammation and neurodegeneration
Open accessAbstract
Low-grade inflammation is a hallmark of old age and a central driver of ageing-associated impairment and disease 1 . Multiple factors can contribute to ageing-associated inflammation 2 ; however, the molecular pathways that transduce aberrant inflammatory signalling and their impact in natural ageing remain unclear. Here we show that the cGAS–STING signalling pathway, which mediates immune sensing of DNA 3 , is a critical driver of chronic inflammation and functional decline during ageing. Blockade of STING suppresses the inflammatory phenotypes of senescent human cells and tissues, attenuates ageing-related inflammation in multiple peripheral organs and the brain in mice, and leads to an improvement in tissue function. Focusing on the ageing brain, we reveal that activation of STING triggers reactive microglial transcriptional states, neurodegeneration and cognitive decline. Cytosolic DNA released from perturbed mitochondria elicits cGAS activity in old microglia, defining a mechanism by which cGAS–STING signalling is engaged in the ageing brain. Single-nucleus RNA-sequencing analysis of microglia and hippocampi of a cGAS gain-of-function mouse model demonstrates that engagement of cGAS in microglia is sufficient to direct ageing-associated transcriptional microglial states leading to bystander cell inflammation, neurotoxicity and impaired memory capacity. Our findings establish the cGAS–STING pathway as a driver of ageing-related inflammation in peripheral organs and the brain, and reveal blockade of cGAS–STING signalling as a potential strategy to halt neurodegenerative processes during old age.
Overview
CoChat Summary
TL;DR
The cGAS–STING pathway drives ageing-related inflammation and neurodegeneration, with STING inhibition reducing inflammatory signatures and improving function in aged mice. In old microglia, cytosolic mtDNA activates cGAS–STING, and microglial cGAS gain-of-function alone is sufficient to induce ageing-associated microglial states, neurotoxicity and memory impairment.
Key findings
- H-151-mediated STING inhibition suppressed proinflammatory and type I IFN-stimulated genes in senescent human cells and human adipose tissue explants, and in aged mice reduced ageing-related immune signatures in kidney, liver and brain.
- In aged mice, STING inhibition improved grip strength and treadmill performance and improved Morris water maze and contextual fear conditioning (fear conditioning P = 3 × 10−5), while reducing hippocampal microgliosis, astrocyte immunoreactivity, CA1 neuron loss and increasing synaptophysin.
- Aged mouse brains showed increased pTBK1 and robust cGAMP production in old but not young brain lysates (n = 9); pSTING was enriched in IBA1+ microglia, and aged microglia accumulated cytosolic mtDNA but not genomic DNA species.
- Microglial cGAS gain-of-function (mg-CgasR241E) induced IFN-, DAM- and neurodegenerative-associated microglial states by snRNA-seq (9,505 cells; 5,360 microglia), impaired Morris water maze performance (P = 1 × 10−5), reduced CA1 neuron density, and caused neuronal death that was rescued by TNF-neutralizing but not IFNAR-neutralizing antibodies.
Methods
- Aged wild-type C57BL/6J and Sting1−/− mice were treated with vehicle or H-151 (750 nmol intraperitoneally, 5 days per week for 8 weeks, then another 8 weeks after a break); CgasR241E mice were generated by CRISPR–Cas9 and crossed to Rosa26-creERT2 or Tmem119-creERT2 for tamoxifen-inducible expression.
- Human adipose tissue explants came from participants with obesity (3 male, 8 female; mean age 48.7 years, s.d. 9.7, range 30–60) and were treated with H-151, DMSO, or quercetin plus dasatinib.
- Main analyses included bulk RNA-seq, single-nucleus RNA-seq, RT–qPCR, immunoblotting, cGAMP ELISA, immunofluorescence/immunohistochemistry, electron microscopy, Airyscan imaging, neuronal co-cultures and behavioural tests, with two-sided t-tests, one-way or two-way ANOVA and Tukey’s or Sidak’s corrections.
Limitations
- The paper states that experimenters were not blinded, no randomization was performed, and data distribution was assumed normal but not formally tested.
- The paper states that elucidating the precise neuroimmune crosstalk downstream of cGAS remains an important area for future investigations.
- Evident from the text: human evidence is limited to adipose tissue explants and senescent cells, not human in vivo ageing; much of the causal evidence comes from mouse models, including a cGAS gain-of-function model rather than natural ageing alone.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. 3 Aberrant cGAS–STING activation in microglia of aged mice involves mtDNA. a, Differential gene expression from bulk hippocampus RNA-seq analysis of young and aged mice treated with or without H-151 (n = 3). The heat map shows type I IFN, MHC class I and microglial activation/disease-associated genes from the total list of significant DEGs (Extended Data Fig. 6a; false-discovery rate (FDR) ≤ 0.01, |log2[fold change (FC)]| ≥ 0.6). b, mRNA expression levels of immunoreactive genes, ISGs and activation markers in primary microglia isolated from young (n = 3) and aged (n = 4) mice. c, Confocal imaging quantification of pSTING staining in young and aged hippocampal sections (average from 100–200 cells per mouse, n = 4), differentially quantified in IBA1− and IBA1+ cells. d, mRNA expression levels of immunoreactive genes and ISGs in microglia from aged mice treated or not with H-151. n = 5. e, Transmission electron microscopy images representing age-related microglial morphological differences and the percentage of disrupted mitochondria per hippocampal microglia in young (n = 13) and aged (n = 10) cells, randomly selected from 3 mice per condition. Scale bars, 1 μm. f, Cytosolic expression levels of Mito (mitochondrial DNA sequence), CoI and B2m in microglia isolated from young and aged mice (n = 4). g, Representative 3D reconstructions from Airyscan images and quantification of cytosolic DNA foci outside the mitochondria in microglia isolated from young and aged mice. The ratio of DNA foci outside the mitochondria was measured for each cell relative to the total counts of cytosolic foci (inside (green) and outside (red)). n = 12 cells, from 3 mice. Scale bars, 5 μm (top) and 1 μm (bottom). Data are mean ± s.e.m. P values were calculated using two-sided unpaired Student’s t-tests (b and d–g) and one-way ANOVA followed by Tukey’s multiple-comparison test (c). Source Data](/paper-figures/bb1f4d4ae3c54dce85e25a7b00d61f0e/cgassting-drives-ageing-related-inflammation-and-neurodegeneration-figure-3.jpg)
![Fig. 4 Selective engagement of cGAS promotes age-associated microglial states and features of neurodegeneration. a, Schematic of the nucleosome-binding-defective cGAS-mutant activation. b, Representative images and quantification of hippocampal IBA1 staining of Tmem119-creERT2-CgasWT/WT and Tmem119-creERT2-CgasWT/R241E mice. n = 5. Scale bars, 200 μm (left) and 50 μm (right). c, Representative IBA1+ microglia reconstructed by IMARIS. Scale bars, 10 μm. d, Brain mRNA expression levels of proinflammatory genes and ISGs from Tmem119-creERT2-CgasWT/WT (n = 5) and Tmem119-creERT2-CgasWT/R241E (n = 6) mice. e, Uniform manifold approximation and projection (UMAP) plots visualizing microglial single nuclei, coloured by cell identity (left, homeostatic microglia (H-MG); disease-associated microglia (DAM-1/2); IFN-associated microglia (IFN-MG); neurodegenerative-associated microglia (ND-MG)), and IFN/DAM gene expression scores split by Cgas genotype (right). Colour scale bars denote the gene burden score. f, DEGs between CgasWT/WT and CgasWT/R241E in IFN-MG and DAM-2-MG (FDR ≤ 0.05, log2[FC] ≥ 0.3). Oversized points represent genes linked with associated states (Supplementary Table 6). g, The relative proportions of microglial populations identified from snRNA-seq analysis of Tmem119-creERT2-CgasWT/WT (WT, n = 3) and Tmem119-creERT2-CgasWT/R241E (R241E, n = 2) microglia. h, Morris water maze test of Tmem119-creERT2-CgasWT/WT (n = 6) and Tmem119-creERT2-CgasWT/R241E (n = 11) mice. P = 1 × 10−5. i, Representative images and quantification of NeuN+ cells in the hippocampal CA1 region of Tmem119-creERT2-CgasWT/WT and Tmem119-creERT2-CgasWT/R241E mice. n = 5. Scale bars, 250 μm (left) and 50 μm (right). j,k, The relative survival of MAP2+ neurons cultured with Rosa26-creERT2-CgasWT/R241E-isolated microglia treated with or without 4-OHT (n = 6) and with TNF-neutralizing (n = 4) or IFNAR-neutralizing antibodies (n = 3 slides), from n = 3 mice (j); or microglia from young and aged mice treated with TNF- or IFNAR-neutralizing antibodies (k) (averaged per mouse, n = 3). Data are mean ± s.e.m. P values were calculated using two-sided Student’s unpaired t-tests (b, d, g and i), one-way ANOVA followed by Tukey’s multiple-comparison test (j and k) and ordinary two-way ANOVA (h). Source Data](/paper-figures/9fca3085e16843dbb405fe941887ebf9/cgassting-drives-ageing-related-inflammation-and-neurodegeneration-figure-4.jpg)










Verification
Claims the paper makes
19 Valid · 0 Not valid · 3 Not checked · 85 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Cells from each of the three states strongly upregulated genes associated with the IFN signature (Ifits, Oasl1, Oasl2, Isg15, Stat2), the DAM-signature (B2m, Ctsb, Ctsd, Ctsz, Cd9, Cd63) and the neurodegenerative signature (Apbb2, Olfr111, Xylt1)38–40 (Supplementary Table 3).”
§ cGAS–STING drives ageing-related inflammation and neurodegeneration > Effect of microglial cGAS on the brain
What the sources say
- Partly supportedcites [38] Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290 (2017). sourceExperimental — accuracy not yet measured
The Results identify CD9 and CD63 as DAM markers and report upregulation of other genes in disease-associated microglia. They do not establish that cells in each of the citing paper’s three states strongly upregulate all three listed signatures; the IFN and neurodegenerative gene lists are not supported by the passages found in our copy. (LLM, conf=0.86)
- Partly supportedcites [39] Friedman, B. A. et al. Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer’s disease not evident in mouse models. Cell Rep. 22, 832–847 (2018). sourceExperimental — accuracy not yet measured
The Results identify an interferon-related module containing Oas and Ifit family genes and Stat2, and report that disease-associated microglia (DAM) express a core neurodegeneration-related gene set. They do not establish that cells in each of the citing paper’s three states strongly upregulate all three listed signatures; in the source’s own clusters, the interferon-related and DAM/neurodegeneration-related modules showed no apparent overlap (Results, Figures 6C′, 6D′ and 6F′). (LLM, conf=0.78)
- Partly supportedcites [40] Sala Frigerio, C. et al. The major risk factors for Alzheimer’s disease: age, sex, and genes modulate the microglia response to Aβ plaques. Cell Rep. 27, 1293–1306 (2019). sourceExperimental — accuracy not yet measured
The Results section, “Aging and Aβ Deposition Induce Similar Responses in Microglia” (page unavailable), identifies an interferon-response cluster that expresses Oasl2 and Ifit genes, and an Aβ-responsive cluster that expresses Ctsb and Ctsd. These passages support some of the cited signature labels, but not the listed neurodegenerative signature. The source does not establish that cells in each of the citing study’s three states upregulate all three signatures; that appears to be the citing authors’ own finding. (LLM, conf=0.84)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We and others have previously described a role of the cGAS–STING pathway in the regulation of cellular senescence—a hallmark of ageing5–8.”
§ cGAS–STING drives ageing-related inflammation and neurodegeneration > Main
What the sources say
- Supportedcites [5] Gluck, S. et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat. Cell Biol. 19, 1061–1070 (2017). source
The Introduction states that the findings establish the cGAS–STING pathway as an important regulator of senescence and the SASP. The Discussion further explains that it regulates cellular senescence predominantly through soluble factors and auto- and paracrine signalling. The Discussion also describes cellular senescence as implicated in ageing. (LLM, conf=0.95)
- Partly supportedcites [6] Yang, H., Wang, H., Ren, J., Chen, Q. & Chen, Z. J. cGAS is essential for cellular senescence. Proc. Natl Acad. Sci. USA 114, E4612–E4620 (2017). sourceExperimental — accuracy not yet measured
The paper’s Discussion states that cGAS is essential for cellular senescence. But the Results section reports that STING deletion did not accelerate spontaneous immortalization and suggests that cGAS may act through a STING-independent mechanism. Thus, the paper supports a role for cGAS, but not an unqualified role for the cGAS–STING pathway in regulating senescence. (LLM, conf=0.87)
- Partly supportedcites [7] Dou, Z. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550, 402–406 (2017). sourceExperimental — accuracy not yet measured
The passage labeled Abstract (page unavailable) shows that cGAS–STING regulates the senescence-associated secretory phenotype (SASP), a key feature of senescence. It also reports that disrupting the pathway does not affect several senescence markers or reverse established senescence, so the broader claim that it regulates cellular senescence needs that qualification. (LLM, conf=0.86)
- Could not verifycites [8] van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439–446 (2014). sourceExperimental — accuracy not yet measured
The 'Causes and effector pathways of senescence' section discusses several pathways that induce senescence, but does not mention cGAS–STING. Searches for cGAS–STING and its expanded name found no passage in our copy linking that pathway to regulation of senescence. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Using explants of human adipose tissue from individuals with obesity, in whom the adipose tissue accumulates senescent preadipocytes12, we confirmed that STING inhibition by H-151 suppressed the release of proinflammatory signals from senescent cells at the tissue level (Extended Data Fig. 3).”
§ cGAS–STING drives ageing-related inflammation and neurodegeneration > STING elicits age-related inflammation
What the sources say
- Partly supportedcites [12] Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246–1256 (2018). sourceExperimental — accuracy not yet measured
The Results section on human adipose tissue reports that obesity is associated with senescent-cell accumulation and that explants from individuals with obesity contained senescent cells. It does not establish that the accumulating cells in those explants were specifically preadipocytes. The citation is attached to that background point, not to the citing authors’ H-151 finding; no page number is available in our copy. (LLM, conf=0.83)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with previous research13, at a very old age (26 months), mice showed an inflammatory and type I IFN signature in the kidneys and the liver (Fig. 1d and Extended Data Fig. 4a,b).”
§ cGAS–STING drives ageing-related inflammation and neurodegeneration > STING elicits age-related inflammation
What the sources say
- Partly supportedcites [13] Almanzar, N. et al. A single-cell transcriptomic atlas characterizes ageing tissues in the mouse. Nature 583, 590–595 (2020). sourceExperimental — accuracy not yet measured
The main text (indexed under Abstract; page unavailable) reports an increased immune signature in ageing liver and a pro-inflammatory macrophage state in older kidneys. It does not report a type I IFN signature in both organs or a finding specifically at 26 months; its interferon-responsive gene finding concerns brain microglia. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These data establish that inhibition of STING, both in cells and in human tissue, can block the inflammatory response of senescent cells—major contributors to inflammation during ageing8.”
§ cGAS–STING drives ageing-related inflammation and neurodegeneration > STING elicits age-related inflammation
What the sources say
- Partly supportedcites [8] van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439–446 (2014). sourceExperimental — accuracy not yet measured
The section ‘Senescence is a multi-step evolving process’ says senescent cells commonly produce proinflammatory factors and can induce local inflammation. But ‘Senescence in ageing and age-related disease’ calls their contribution to chronic inflammation during ageing an untested idea, so the source does not establish that they are major contributors. The citation is attached to that description of senescent cells, not to the citing authors’ STING-inhibition result. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
53 more claims · 5 with their cited sources checked
Create a free account to see all 107 claims and every source verdict.
- Probably not a substantial claim. 27
- It may state two separate claims as one. 32
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent study on naturally aged mice found that in the absence of an additional trigger, the activation of cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling pathway is sufficient to promote aging-related inflammation and neurodegeneration by triggering reactive microglial transcriptional states.112”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Similar findings have been reported in the context of physiological aging (Gulen et al. 2023) and other age-related neurodegenerative disorders ( Supplemental Table 1 ).”
From The Role of Retrotransposons and Endogenous Retroviruses in Age-Dependent Neurodegenerative Disorders (2024) · cites this paper as Gulen et al. 2023
In the citing paper
“Targeting age-related inflammation is beneficial for the management of neurodegenerative diseases.482”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [482]
In the citing paper
“Interestingly, the cGAS-STING signalling axis has been recently shown to drive chronic inflammation and functional decline during ageing in mice, with neuroprotective effects achieved using the H151 inhibitor 71 .”
From AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain (2025) · cites this paper as [71]
In the citing paper
“cGAS–STING, IFNα and TNF signalling pathways are well recognized for altering microglial phenotypes to neuropathic states62–64.”
From Immune checkpoint TIM-3 regulates microglia and Alzheimer’s disease (2025) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ cGAS–STING drives ageing-related inflammation and neurodegeneration > Effect of microglial cGAS on the brain
“5,360 microglia obtained from tamoxifen-treated mg-CgasR241E mice and control CgasWT/R241E mice”
§ cGAS–STING drives ageing-related inflammation and neurodegeneration > Effect of microglial cGAS on the brain
“The relative proportions of microglial populations identified from snRNA-seq analysis of Tmem119-creERT2-CgasWT/WT (WT, n = 3) and Tmem119-creERT2-CgasWT/R241E (R241E, n = 2) microglia.”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Sliter, D. A. et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature 561, 258–262 (2018).”
Cited work 10.1038/s41586-018-0448-9 · retracted 2025-07-30 · notice 10.1038/s41586-025-09346-8 · this paper published 2023-08-02
Citations
Cites
1 retracted
RETRACTED ARTICLE: Parkin and PINK1 mitigate STING-induced inflammation
Sliter, D. A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T. D., Burman, J. L., Li, Y., Zhang, Z., Narendra, D. P., et al. (2018) · Nature · doi:10.1038/s41586-018-0448-9 · Cited by 1,287
RetractedIntegrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586
Finak, G., McDavid, A., Yajima, M., Deng, J., Gersuk, V., Shalek, A. K., Slichter, C. K., Miller, H. W., McElrath, M. J., Prlic, M., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0844-5 · Cited by 3,159
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Cited by
Mitochondrial dysfunction: mechanisms and advances in therapy
Zong, Y., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,172
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
The senescence-associated secretory phenotype and its physiological and pathological implications
Wang, B., Han, J., Elisseeff, J. H., & Demaria, M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00727-x · Cited by 948
“Notably, cytosolic DNA released from mitochondria and cGAS–STING were shown to be the drivers of ageing-associated and SASP-like low-grade inflammation 104 .”
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
Self-citationFleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 544
Metadata
- Authors
- Gulen, M. F., Samson, N., Keller, A., Schwabenland, M., Liu, C., Glück, S., Thacker, V. V., Favre, L., Mangeat, B., Kroese, L. J., Krimpenfort, P., Prinz, M., & Ablasser, A.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- University of Freiburg (DE)
- Centre Hospitalier Universitaire Vaudois (CH)
- The Netherlands Cancer Institute (NL)
- ISREC Foundation (CH)
- Corresponding author
- Ablasser, Andrea
- ORCID
- Venue
- Nature
- Published
- 2023-08-02
- Volume
- 620
- Issue
- 7973
- Pages
- 374-380
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC10412454
- OpenAlex
- W4385498418
- Cited by
- 1,104
- References
- 63
- Citations by year
- 2026: 439 · 2025: 361 · 2024: 271 · 2023: 33
- FWCI
- 119.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion, cc-by)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (188759, 213681, 310030)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- neurodegeneration, cognitive decline, microglia, cytosolic DNA, mitochondrial dysfunction, cellular senescence, hippocampus
- MeSH terms
- STING Protein, Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase, Aging, Animals, Brain, DNA, Hippocampus, Humans, Inflammation, Membrane Proteins, Memory Disorders, Mitochondria, Nucleotidyltransferases, Organ Specificity, Signal Transduction, Microglia, Neurodegenerative Diseases, Bystander Effect, Mice, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: cGAS–STING drives ageing-related inflammation and neurodegeneration. https://app.cochat.ai/papers/10.1038/s41586-023-06373-1
- The paper
- Gulen, M. F., Samson, N., Keller, A., Schwabenland, M., Liu, C., Glück, S., Thacker, V. V., Favre, L., Mangeat, B., Kroese, L. J., Krimpenfort, P., Prinz, M., & Ablasser, A. (2023). cGAS–STING drives ageing-related inflammation and neurodegeneration. Nature. https://doi.org/10.1038/s41586-023-06373-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.